Axon Enterprise
AXON
406.00
-12.62
-3.01%
Axon Enterprise
US · AXON
#612 by market cap
Listed 1970
406.00
-12.62
-3.01%
Live - 5344 symbols - heartbeat 96s ago
· 2026-10-08 08:39
Pre-market
405.26
-0.18%
After-hours
407.00
+0.25%
Overnight
405.68
-0.08%
- Market cap
- 32.98B
- P/E (TTM)i
- 169.17
- P/Bi
- 8.98
- EPSi
- 1.51
- Div yieldi
- 0.00%
- 52W posi
- 16%
Reader sentiment
Are you bullish or bearish on AXON?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 6.21, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +33.47% YoY
Margins
- Gross margin
- 59.65%
- Operating margin
- -2.23%
- Net margin
- 4.48%
Key ratios & quality
- Enterprise valuei
- 33.06B
- Altman Z-Scorei
- 6.21
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 420.07M | 530.86M | 681.00M | 863.38M | 1.19B | 1.56B | 2.08B | 2.78B |
| Gross profit | 258.58M | 307.29M | 416.33M | 540.91M | 726.11M | 955.45M | 1.24B | 1.66B |
| Selling & admin expenses | 150.84M | 212.96M | 307.29M | 515.01M | 399.33M | 494.88M | 741.25M | 1.04B |
| Research & development | 76.86M | 100.72M | 123.20M | 194.03M | 233.81M | 303.72M | 441.59M | 684.31M |
| Operating profit | 24.84M | -6.39M | -14.15M | -168.12M | 92.97M | 156.85M | 58.54M | -62.08M |
| Pretax profit | 28.10M | 2.07M | -6.29M | -141.38M | 196.24M | 157.06M | 381.50M | 18.97M |
| Tax | -1.10M | 1.19M | -4.57M | -81.36M | 49.31M | -18.72M | 4.47M | -105.68M |
| Net profit | 29.21M | 882.00K | -1.72M | -60.02M | 146.93M | 175.78M | 377.03M | 124.66M |
| Basic EPS | 1 | 0 | 0 | -1 | 2 | 2 | 5 | 2 |
| Diluted EPS | 0.50 | 0.01 | -0.03 | -0.91 | 2.03 | 2.33 | 4.80 | 1.51 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 603.63M | 668.54M | 710.64M | 796.72M | 807.35M | 904.39M |
| Gross profit | 365.74M | 403.74M | 427.35M | 461.30M | 477.29M | 546.45M |
| Selling & admin expenses | 223.51M | 242.21M | 252.80M | 317.37M | 259.09M | 290.98M |
| Research & development | 151.02M | 162.57M | 176.67M | 194.04M | 188.95M | 208.69M |
| Operating profit | -8.79M | -1.04M | -2.13M | -50.12M | 29.24M | 46.78M |
| Pretax profit | 108.39M | -38.88M | 15.70M | -66.24M | 200.22M | 32.68M |
| Tax | 20.41M | -75.00M | 17.89M | -68.98M | 30.91M | 3.26M |
| Net profit | 87.98M | 36.12M | -2.19M | 2.75M | 169.31M | 29.43M |
| Basic EPS | 1 | 0 | 0 | 0 | 2 | 0 |
| Diluted EPS | 1.08 | 0.44 | -0.03 | 0.03 | 2.05 | 0.36 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 558.16M | 609.48M | 981.95M | 1.11B | 1.81B | 2.39B | 2.30B | 3.71B |
| Cash & ST investments | 349.46M | 350.78M | 561.97M | 443.02M | 974.69M | 1.32B | 986.35M | 1.73B |
| Inventory | 33.76M | 38.85M | 89.96M | 108.69M | 202.47M | 269.86M | 265.32M | 341.81M |
| Total assets | 719.54M | 845.64M | 1.38B | 1.69B | 2.85B | 3.41B | 4.47B | 7.00B |
| Total current liabilities | 166.01M | 195.57M | 256.33M | 418.52M | 602.65M | 761.54M | 1.68B | 1.47B |
| Short-term debt | -- | -- | -- | -- | -- | -- | 680.29M | 80.55M |
| Long-term debt | -- | -- | -- | -- | 673.97M | 677.11M | -- | 1.73B |
| Total liabilities | 252,216,000.00 | 302,144,000.00 | 404,768,000.00 | 640,361,000.00 | 1,583,403,000.00 | 1,793,409,000.00 | 2,146,923,000.00 | 3,757,655,000.00 |
| Total equity | 467.32M | 543.50M | 976.26M | 1.05B | 1.27B | 1.62B | 2.33B | 3.24B |
| Retained earnings | 171.38M | 172.27M | 169.90M | 109.88M | 257.02M | 434.98M | 812.01M | 936.67M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 3.78B | 3.83B | 4.22B | 3.71B | 2.74B | 3.00B |
| Cash & ST investments | 2.37B | 2.23B | 2.44B | 1.73B | 736.97M | 692.53M |
| Inventory | 279.67M | 308.49M | 317.51M | 341.81M | 408.01M | 486.56M |
| Total assets | 6.08B | 6.22B | 6.66B | 7.00B | 7.07B | 7.48B |
| Total current liabilities | 1.34B | 1.30B | 1.35B | 1.47B | 1.21B | 1.40B |
| Short-term debt | 278.92M | 279.25M | 279.56M | 80.55M | -- | -- |
| Long-term debt | 1.73B | 1.73B | 1.73B | 1.73B | 1.73B | 1.73B |
| Total liabilities | 3,527,306,000.00 | 3,482,856,000.00 | 3,629,615,000.00 | 3,757,655,000.00 | 3,532,736,000.00 | 3,806,620,000.00 |
| Total equity | 2.56B | 2.73B | 3.03B | 3.24B | 3.53B | 3.67B |
| Retained earnings | 899.99M | 936.11M | 933.93M | 936.67M | 1.11B | 1.14B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 63.88M | 65.67M | 38.48M | 124.49M | 235.36M | 189.26M | 408.31M | 211.34M |
| Depreciation & amortization | 10.62M | 11.36M | 12.48M | 18.69M | 23.12M | 19.32M | 48.43M | 83.16M |
| Free cash flow | 52.18M | 49.33M | -34.39M | 74.22M | 179.56M | 129.63M | 329.53M | 75.08M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 233.99M | 0 | 306.78M | 105.51M | -74.00K | 94.71M | 0 | 489.55M |
| Ending cash balance | 351.03M | 172.36M | 155.55M | 356.44M | 355.55M | 600.67M | 466.76M | 1.21B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 25.79M | -91.70M | 60.01M | 217.24M | -31.52M | 20.08M |
| Depreciation & amortization | 19.45M | 17.16M | 19.61M | 26.95M | 30.36M | 32.46M |
| Free cash flow | 932.00K | -114.66M | 33.38M | 155.43M | -54.64M | -972.00K |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 183.96M | 178.28M | 127.31M | 0 | 100.48M |
| Ending cash balance | 1.10B | 627.46M | 1.44B | 1.21B | 471.16M | 609.62M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 9.20 | 0.17 | -0.23 | -5.93 | 12.70 | 12.10 | 19.14 | 4.48 |
| ROA %i | 5.52 | 0.11 | -0.15 | -3.91 | 6.48 | 5.54 | 9.53 | 2.17 |
| ROIC %i | 9.20 | -1.05 | -0.98 | -7.86 | 3.73 | 6.65 | 12.69 | 3.35 |
| 5-year avg ROE %i | 10.88 | 7.56 | 4.73 | 1.30 | 3.18 | 3.78 | 7.57 | 8.51 |
| EBIT margin %i | 5.91 | -1.20 | -2.08 | -19.47 | 7.84 | 10.36 | 18.66 | 4.07 |
| FCF / sales %i | 12.42 | 9.29 | -- | 8.60 | 15.06 | 8.25 | 15.82 | 2.70 |
| Current ratioi | 3.36 | 3.12 | 3.83 | 2.65 | 3.00 | 3.14 | 1.37 | 2.53 |
| Quick ratioi | 2.98 | 2.74 | 3.34 | 2.26 | 2.54 | 2.65 | 1.13 | 2.10 |
| Debt / assetsi | -- | -- | -- | 1.21 | 24.93 | 20.85 | 16.13 | 27.28 |
| LT debt / equityi | -- | -- | -- | 1.95 | 56.06 | 43.98 | 1.78 | 56.41 |
| Interest coveragei | -- | -- | -- | -- | -- | 23.16 | 54.75 | 1.20 |
| Revenue CAGR (3Y) %i | 28.52 | 25.55 | 25.59 | 27.14 | 30.77 | 31.84 | 34.11 | 32.79 |
| Net income CAGR (3Y) %i | 13.58 | -62.92 | -- | -- | 450.23 | -- | -- | -5.33 |
| FCF CAGR (3Y) %i | 9.32 | 57.26 | -- | 12.46 | 53.83 | -- | 64.36 | -25.22 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 15.17 | 14.00 | 10.03 | 4.48 | 6.76 | 6.22 |
| ROA %i | 6.84 | 6.55 | 4.82 | 2.17 | 3.13 | 2.91 |
| ROIC %i | 8.37 | 8.20 | 6.29 | 3.35 | 4.74 | 4.65 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 15.14 | 11.44 | 9.27 | 4.07 | 7.57 | 9.22 |
| FCF / sales %i | 16.29 | 7.38 | 5.67 | 2.70 | 0.65 | 4.14 |
| Current ratioi | 2.83 | 2.95 | 3.12 | 2.53 | 2.27 | 2.15 |
| Quick ratioi | 2.50 | 2.56 | 2.73 | 2.10 | 1.70 | 1.58 |
| Debt / assetsi | 33.65 | 33.01 | 31.53 | 27.28 | 25.87 | 24.51 |
| LT debt / equityi | 69.17 | 64.86 | 60.10 | 56.41 | 51.73 | 49.90 |
| Interest coveragei | 25.61 | 6.84 | 3.52 | 1.20 | 1.96 | 2.59 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Connected Devices is the largest reported line at 56.01% of revenue, across 2 reported segments.
- Software and Services follows at 43.99%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Connected Devices56.01%
Software and Services43.99%
Quote time 2026-10-08 08:39:33 · For reference only, not investment advice and not tailored to your situation.